Evidence map›Paper›PMID 26574491›Full record

Observational studyJournal of Crohn's & colitis2016

Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.

Giuseppina Liguori, Bruno Lamas, Mathias L Richard, Giovanni Brandi, Gregory da Costa, Thomas W Hoffmann, Massimo Pierluigi Di Simone, Carlo Calabrese, Gilberto Poggioli, Philippe Langella and 2 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Journal of Crohn's & colitis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 202 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 1 synthesis or guideline pooled it, 333 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Infection and immunity · 2025
    Review
  17. Review
  18. Review
  19. Article
  20. Article

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Giuseppina LiguoriDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Bruno LamasEquipe Avenir Gut Microbiota and Immunity, U1157/UMR7203, Faculté de Médecine Saint-Antoine, Université Pierre et Marie Curie, Paris, France Inflammation-Immunopathology-Biotherapy Département, Hospitalo-Universitaire, Paris, France.
Mathias L RichardInflammation-Immunopathology-Biotherapy Département, Hospitalo-Universitaire, Paris, France INRA, UMR1319 MICALIS, Jouy en Josas, France AgroParisTech, UMR1319 MICALIS, Jouy en Josas, France.
Giovanni BrandiDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Gregory da CostaInflammation-Immunopathology-Biotherapy Département, Hospitalo-Universitaire, Paris, France INRA, UMR1319 MICALIS, Jouy en Josas, France AgroParisTech, UMR1319 MICALIS, Jouy en Josas, France.
Thomas W HoffmannInflammation-Immunopathology-Biotherapy Département, Hospitalo-Universitaire, Paris, France INRA, UMR1319 MICALIS, Jouy en Josas, France AgroParisTech, UMR1319 MICALIS, Jouy en Josas, France.
Massimo Pierluigi Di SimoneDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Carlo CalabreseDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Gilberto PoggioliDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Philippe LangellaInflammation-Immunopathology-Biotherapy Département, Hospitalo-Universitaire, Paris, France INRA, UMR1319 MICALIS, Jouy en Josas, France AgroParisTech, UMR1319 MICALIS, Jouy en Josas, France.
Massimo CampieriDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Harry SokolEquipe Avenir Gut Microbiota and Immunity, U1157/UMR7203, Faculté de Médecine Saint-Antoine, Université Pierre et Marie Curie, Paris, France Inflammation-Immunopathology-Biotherapy Département, Hospitalo-Universitaire, Paris, France INRA, UMR1319 MICALIS, Jouy en Josas, France AgroParisTech, UMR1319 MICALIS, Jouy en Josas, France Service de Gastroentérologie et Nutrition, Assistance Publique Hôpitaux de Paris et Université Paris6, Paris, France. harry.sokol@aphp.fr.
University of Bologna · ITAgroParisTech · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsGut microbiota is involved in many physiological functions and its imbalance is associated with several diseases, particularly with inflammatory bowel diseases. Mucosa-associated microbiota could have a key role in induction of host immunity and in inflammatory process. Although the role of fungi has been suggested in inflammatory disease pathogenesis, the fungal microbiota has not yet been deeply explored. Here we analysed the bacterial and fungal composition of the mucosa-associated microbiota of Crohn's disease patients and healthy subjects.

methodsOur prospective, observational study evaluated bacterial and fungal composition of mucosa-associated microbiota of 23 Crohn's disease patients [16 in flare, 7 in remission] and 10 healthy subjects, using 16S [MiSeq] and ITS2 [pyrosequencing] sequencing, respectively. Global fungal load was assessed by real time quantitative polymerase chain reaction.

resultsBacterial microbiota in Crohn's disease patients was characterised by a restriction in biodiversity. with an increase of Proteobacteria and Fusobacteria. Global fungus load was significantly increased in Crohn's disease flare compared with healthy subjects [p < 0.05]. In both groups, the colonic mucosa-associated fungal microbiota was dominated by Basidiomycota and Ascomycota phyla. Cystofilobasidiaceae family and Candida glabrata species were overrepresented in Crohn's disease. Saccharomyces cerevisiae and Filobasidium uniguttulatum species were associated with non-inflamed mucosa, whereas Xylariales order was associated with inflamed mucosa.

conclusionsOur study confirms the alteration of the bacterial microbiota and is the first demonstration of the existence of an altered fungal microbiota in Crohn's disease patients, suggesting that fungi may play a role in pathogenesis.

Indexed as

Gastrointestinal MicrobiomeAdultBiodiversityCase-Control StudiesColonCrohn DiseaseDisease ProgressionDNA, FungalDysbiosisFemaleFungiHumansIntestinal MucosaMaleMiddle AgedProspective StudiesDNA, Fungalfungal microbiotaInflammatory bowel diseasemucosa-associated microbiota

Identifiers

PMID26574491
PMCPMC4957473
OpenAlexW2191014442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.